Inventor · disambiguated record
Takemasa Tsuji
Also filed as: TSUJI TAKEMASA
14 granted patents·10 pending applications·59 citations·filing 2012–2023
91Inventor score
Files withAGENUS INC14HEALTH RESEARCH INC7LUDWIG INST CANCER RES1ROSWELL PARK CANCER INST CORPORATION1TSUJI TAKEMASA1
Top patents by PatentIndex Score
24 records- 0197US10836830B2Antibodies and methods of use thereofAGENUS INC·Filed 2020·Granted Nov 17, 2020·12 cites·45 claims
- 0296US10280226B2Anti-GITR antibodies and methods of use thereofAGENUS INC·Filed 2018·Granted May 7, 2019·17 cites·30 claims
- 0396US10155818B2Anti-GITR antibodies and methods of use thereofAGENUS INC·Filed 2015·Granted Dec 18, 2018·17 cites·4 claims
- 0488US10800849B2Anti-GITR antibodies and methods of use thereofAGENUS INC·Filed 2018·Granted Oct 13, 2020·2 cites·26 claims
- 0587US10577426B2Anti-GITR antibodies and methods of use thereofAGENUS INC·Filed 2018·Granted Mar 3, 2020·3 cites·21 claims
- 0684US11447557B2Antibodies and methods of use thereofAGENUS INC·Filed 2016·Granted Sep 20, 2022·3 cites·46 claims
- 0784US10829559B2Anti-GITR antibodies and methods of use thereofAGENUS INC·Filed 2019·Granted Nov 10, 2020·1 cites·8 claims
- 0882US2023039577A1Anti-gitr antibodies and methods of use thereofAGENUS INC·Filed 2022·Application pending·0 cites
- 0980US2023406946A1Antibodies and methods of use thereofAGENUS INC·Filed 2022·Application pending·0 cites
- 1080US2023399413A1Antibodies and methods of use thereofAGENUS INC·Filed 2022·Application pending·0 cites
- 1177US10000546B2Compositions and method for use of recombinant T cell receptors for direct recognition of tumor antigenHEALTH RESEARCH INC·Filed 2014·Granted Jun 19, 2018·4 cites·3 claims
- 1275US11897962B2Anti-GITR antibodies and methods of use thereofAGENUS INC·Filed 2020·Granted Feb 13, 2024·0 cites·11 claims
- 1373US11401335B2Anti-GITR antibodies and methods of use thereofAGENUS INC·Filed 2020·Granted Aug 2, 2022·0 cites·16 claims
- 1472US12371470B2Compositions and methods for use of recombinant T cell receptors for direct recognition of tumor antigenHEALTH RESEARCH INC·Filed 2021·Granted Jul 29, 2025·0 cites·5 claims
- 1572US2021171648A1Antibodies and methods of use thereofAGENUS INC·Filed 2020·Application pending·0 cites
- 1665US11155595B2Compositions and methods for use of recombinant T cell receptors for direct recognition of tumor antigenHEALTH RESEARCH INC·Filed 2018·Granted Oct 26, 2021·0 cites·3 claims
- 1761US2014255436A1Immunogenic compositions useful in provoking an integrated response to tumor antigensLUDWIG INST CANCER RES·Filed 2014·Application pending·0 cites
- 1860US2024408202A1FOLATE RECEPTOR ALPHA -TARGETING BI-SPECIFIC T CELL ENGAGERS (BiTEs) AND USES THEREOFHEALTH RESEARCH INC·Filed 2023·Application pending·0 cites
- 1955US2012328660A1Immunogenic compositions useful in provoking an integrated response to tumor antigensTSUJI TAKEMASA·Filed 2012·Application pending·0 cites
- 2054US2025057881A1Compositions and methods for use of recombinant t cell receptors against claudin 6ROSWELL PARK CANCER INST CORPORATION·Filed 2022·Application pending·0 cites
- 2148US2021268087A1Major histocompatibility complex class ii-expressing cancer cell vaccine and methods of use for producing integrated immune responsesHEALTH RESEARCH INC·Filed 2019·Application pending·0 cites
- 2241US2020123265A1Anti-gitr antibodies and methods of use thereofAGENUS INC·Filed 2016·Application pending·0 cites
- 2335US12275946B2Compositions and methods for rapid cloning of t-cell receptorsHEALTH RESEARCH INC·Filed 2017·Granted Apr 15, 2025·0 cites·20 claims
- 2435US11020431B2Compositions and libraries comprising recombinant T-cell receptors and methods of using recombinant T-cell receptorsHEALTH RESEARCH INC·Filed 2017·Granted Jun 1, 2021·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Takemasa Tsuji files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →